President Trump just delivered a concrete win for American seniors: lower Medicare costs on expensive outpatient drugs, imaging services, and more.
The Centers for Medicare & Medicaid Services has finalized a 2027 rule projected to save Medicare beneficiaries $1.1 billion on outpatient drug costs next year alone.
For seniors receiving qualifying drugs at hospital outpatient departments, the average savings is expected to reach roughly $900 in 2027.
The White House put the bottom line front and center:
New Medicare policies will lower costs by more than BILLION for seniors next year.
— The White House (@WhiteHouse) November 5, 2026
Effective policy to help the American people where they need it most. 🇺🇸 pic.twitter.com/jW8qwrNarp
CMS says the reform targets a glaring payment problem involving drugs purchased through the federal 340B discount program. A federal survey found hospitals were acquiring those drugs at prices far below the benchmark Medicare had been using to reimburse them.
Under the finalized rule, Medicare payments for 340B drugs will be tied more closely to documented acquisition costs. CMS projects $1.1 billion in lower beneficiary drug payments and another $4.35 billion in taxpayer savings in 2027, reducing total drug spending by approximately $5.45 billion.
In plain English: the Trump administration is making sure huge hospital discounts are no longer swallowed up while seniors keep paying inflated co-pays.
CMS confirmed the rule will also expand outpatient surgery options and tighten oversight:
CMS released a rule to expand outpatient surgery options, lower out-of-pocket costs for imaging services and 340B drugs, and strengthen oversight of select services. The rule also updates 2027 payment rates for hospital outpatient departments and ambulatory surgical centers.… pic.twitter.com/noo2wyaYyZ
— CMSGov (@CMSGov) November 5, 2026
The savings extend beyond prescription drugs.
Medicare patients can currently face different co-pays for the same imaging service depending on whether it is performed in a doctor's office or an off-campus hospital department. The new policy applies the lower physician-office payment rate to certain bone-density scans, X-rays, ultrasounds, CT scans, and MRIs performed at those hospital-affiliated locations.
CMS estimates that imaging change will save beneficiaries and taxpayers $260 million in 2027 and more than $9 billion over the following decade. Beneficiary cost-sharing alone is expected to fall by about $70 million in the first year.
The rule also continues phasing out Medicare's "Inpatient Only" procedure list and adds hundreds of procedures to the list that can be performed at ambulatory surgical centers. That gives doctors more flexibility to select an appropriate care setting while offering patients more lower-cost outpatient options.
At the same time, CMS is adding prior-authorization requirements for eight botulinum-toxin injection billing codes after claims for those services jumped 42.8% from 2017 through 2024, even as overall hospital outpatient volume declined. Medically necessary treatments remain covered, including injections for chronic migraines.
The outpatient rule arrives alongside a broader Medicare modernization push. A separate physician-payment rule announced this week emphasizes prevention, primary care, coordinated treatment, and controls on duplicate billing.
Health and Human Services described the administration's direction this way:
America's healthcare system should reward keeping people healthy, not just treating them when they're sick. Under @POTUS' leadership, HHS and @CMSGov are modernizing Medicare to put patients first.
— HHS (@HHSGov) November 5, 2026
✅ Prioritizing prevention and primary care
✅ Expanding access to preventive… pic.twitter.com/56PFNwnHWi
CMS explains that the final rule updates payment policies affecting roughly 3,500 hospitals and 6,400 ambulatory surgical centers beginning in calendar year 2027. The agency based its 340B drug-payment change on a nationwide acquisition-cost survey conducted from January through early April 2026.
That survey found some Medicare beneficiary co-pays were actually higher than the total price a hospital paid for the drug. The finalized formula will pay for 340B-acquired drugs at the average sales price minus 28%, bringing reimbursement closer to documented hospital costs.
CMS is exempting rural Sole Community Hospitals from the new imaging payment policy. The 340B change is also required to remain budget-neutral inside the outpatient payment system, meaning the drug savings will be balanced by higher payments for non-drug hospital services rather than disappearing from the program.
The agency says the reforms are designed to preserve access while stopping Medicare and its beneficiaries from paying more simply because care was delivered in a higher-cost setting.
That is the kind of reform Washington should have been delivering all along: expose the inflated payment, pass the savings to seniors, protect taxpayers, and give patients more choices.
President Trump promised to put Americans first. For seniors facing expensive treatments and stubborn healthcare bills, this rule turns that promise into dollars they can keep.
Source link
